Literature DB >> 23012492

Respondent driven sampling--where we are and where should we be going?

Richard G White, Amy Lansky, Sharad Goel, David Wilson, Wolfgang Hladik, Avi Hakim, Simon D W Frost.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23012492      PMCID: PMC3461761          DOI: 10.1136/sextrans-2012-050703

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


× No keyword cloud information.
Respondent Driven Sampling (RDS) is a novel variant of link tracing sampling that has primarily been used to estimate the characteristics of hard-to-reach groups, such as the HIV prevalence of drug users.1 ‘Seeds’ are selected by convenience from a population of interest (target population) and given coupons. Seeds then use these coupons to recruit other people, who themselves become recruiters. Recruits are given compensation, usually money, for taking part in the survey and also an incentive for recruiting others. This process continues in recruitment ‘waves’ until the survey is stopped. Estimation methods are then applied to account for the biased recruitment, for example, the presumed over-recruitment of people with more acquaintances, in an attempt to generate estimates for the underlying population. RDS has quickly become popular and relied on by major public health organisations, including the US Centers for Disease Control and Prevention and Family Health International, chiefly because it is often found to be an efficient method of recruitment in hard-to-reach groups, but also because of the availability of custom written software incorporating inference methods that are designed to generate estimates that are representative of the wider population of interest, despite the biased sampling. As demonstrated by RDS's popularity,1 there was a clear need for new methods of data collection on hard-to-reach groups. However, RDS has not been without its critics. Its reliance on the target population for recruitment introduced ethicalw1 and sampling concerns.w2 If RDS estimates are overly biased or the variance is unacceptably high, then RDS will be little more than another method of convenience sampling. If these errors can be minimised however, then RDS has the potential to become a very useful survey methodology. In this editorial we highlight that ‘RDS’ includes both data collection and statistical inference methods, discuss the limitations of current RDS inference methods for generating representative estimates, highlight other applications of RDS for which it may be more reliable, propose and request feedback on a draft RDS reporting checklist, and finally suggest priority areas for RDS research. As commonly discussed, RDS is actually a collection of methods to carry out two primary tasks, a method to sample a population and a method of statistical inference to generate population estimates.2 A custom-written computer package, ‘RDSAT’, has been released to assist with data handling, tabulation and inference.3 The RDS method of sampling is often efficient, with samples usually accruing quickly and with minimal perceived need for intervention by project staff, and has led to the collection of a wealth of data.1 Lessons learned from the design and implementation of RDS have been shared and coalesced into standard protocols for data collection.w3 However, the performance of the inference methods is far less certain. There is much disagreement and confusion about the suitability and utility of the current methods of statistical inference and therefore the ability of RDS to generate representative data. Current inference methods rely on multiple assumptions of the sampling process, most of which may not be met in practice.4 5 w4 Hence, in retrospect, it might seem reasonable to expect that RDS estimates are likely to suffer from (perhaps large) error. Unfortunately, we really do not know if this is true or not, because there have been few robust evaluations. This is in part because such evaluations are methodologically challenging to carry out. The representative or total-population data that are required are generally unavailable for hard-to-reach groups (hence the need for RDS). The most convincing studies that do exist (see5–7; Goel et al7 also has a useful summary of other evaluations) suggest that RDS samples (i) may indeed suffer from bias and the bias may be difficult to detect, (ii) that the current inference methods do not reduce these biases, and perhaps most importantly, (iii) estimates probably have higher variance than initially thought. The latter is important because it means sample sizes in the thousands may be required to get the levels of precision currently assumed obtainable from sample sizes in the hundreds, and would therefore make RDS studies substantially larger, longer and more expensive than current common practice. The practical implications of these findings are that when interpreting RDS surveys that make statements about the wider population beyond the sample, CIs should be assumed to be too narrow, and adjustments should not be assumed to have made the unadjusted estimates more representative. Readers should also consider the unadjusted estimates and how representative they might be of the wider population. That said, generating representative estimates is one of the most difficult things we could ask of RDS. Other potential applications for the RDS method or data collected using RDS include risk factor identification,w5 social network data collection,w6 population size estimation,w7 and implementation of interventions.w8 These other applications require fewer (or no) sampling assumptions be met. RDS might not be a panacea, but could still be the best method to collect data on many hard-to-reach groups. However, it is critical that the concerns about statistical inference be addressed, and the current benefits and limitations of RDS be better communicated to the broader public health community. Another concern is that currently RDS studies are not being adequately reported.1 Ultimately his reduces the utility of published data and hinders assessment of study quality. Development of specific RDS reporting guidelines will assist in the interpretation of estimates and findings from RDS studies and in the evaluation of the RDS method itself. To facilitate this process, we have drafted a RDS study reporting checklist (Summary in table 1; Full version in web appendix table W1 or on Equator Network website8) that we have adapted from the STROBE guidelinesw9 for cross-sectional studiesw10 after receiving feedback from RDS experts contacted via the RDS list serverw11 and personal contacts. We invite further comments on the full draft checklist (web appendix table W1), either directly to the corresponding author, a Rapid Response on the STI website, or via the Equator Network website.8 These comments will feed directly into a planned guidelines-setting meeting during which the contents of this checklist and the accompanying guidelines will be discussed and hopefully a consensus reached, followed by formal publication of the resulting guidelines.
Table 1

Summary of proposed additional information to be reported for RDS studies (STROBE-RDS study reporting checklist)

Proposed additional information to be reported for RDS studies
Title and abstractIndicate the study's design (Respondent-Driven Sampling) in the title or abstract
Methods
 Study designState why RDS is considered the most appropriate sampling method
 SettingDescribe formative research methods and findings used to inform RDS study design
 ParticipantsGive the eligibility criteria, number, sources and methods of seed selection
State if additional seeds were required, and if so, when and how recruited and started
State if there was any variation in study design during data collection (eg, changing numbers of coupons per recruit, or stopping chains)
Give the eligibility criteria for subsequent recruits if it differs from seeds
Give number, types (eg, mobile/static) and location of recruitment venue(s)
Report wording of network size question(s)
 VariablesState if and how recruiter-recruit relationship was tracked
 Data sources/measurementDescribe methods to assess eligibility and reduce repeat enrolment (eg, coupon manager software, biometrics, detection of commercial exchange of coupons)
Quality checks (eg, were returned coupons actually distributed and redeemed only once?)
 Statistical methodsDescribe all statistical methods, including name and description of the analytical methods (ie, point and interval estimators) used to take account of RDS sampling strategy. Report software package/version number and settings values
Report any criteria used to support statements on whether estimator conditions or assumptions were met, for example, ‘RDS equilibrium reached’
State if seeds included in each analysis
Results
 ParticipantsReport numbers of individuals at each stage of study, that is, final number of seeds, number examined for eligibility, number confirmed eligible, number included in study, number returned for incentive collection and (if applicable) re-interview, and number analysed
Give reasons for non-participation at each stage, including reason for coupon rejection
Report number of coupons distributed and returned
Report number of recruits by seed and number of RDS recruitment waves
 Main resultsReport unadjusted estimates and their stated precision (eg, 95% CI)
If applicable, report adjusted estimates and their stated precision (eg, 95% CI)
If adjusted estimates presented, report enough information so that the reason for the magnitude of the adjustment is clear (eg, network sizes and homophily by group)
 Other analysesReport other sensitivity analyses for example, different RDS estimators, different network size definitions
Discussion
 LimitationsConsider limitations of RDS sampling method and, if used, the RDS method(s) of inference. Include comment on how representative the unadjusted sample is thought to be

Note: this is a summary of the full checklist. See web appendix table W1 or the Equator Network website8 for full details. Guidelines development proceeding according to Moher et al 2010.w12 Checklist adapted from STROBE guidelinesw9 checklist for cross-sectional studies.w10

RDS, Respondent Driven Sampling.

Summary of proposed additional information to be reported for RDS studies (STROBE-RDS study reporting checklist) Note: this is a summary of the full checklist. See web appendix table W1 or the Equator Network website8 for full details. Guidelines development proceeding according to Moher et al 2010.w12 Checklist adapted from STROBE guidelinesw9 checklist for cross-sectional studies.w10 RDS, Respondent Driven Sampling. There are many current priority areas for RDS research. There needs to be a clearer distinction between the methods used for RDS sampling and the methods used for statistical inference. There is a need for more systematic reporting of RDS studies. There is a critical need for more robust empirical evaluations to measure RDS sampling errors (bias, and variance if possible) in a range of different populations as context is likely to be important. Current efforts to develop new inference methods should be intensified,9 10 and more focus should be given to designing diagnostics to identify when problems are occurring during RDS recruitment. If problems are detected during data collection, steps could be taken to alleviate these problems immediately by correcting the problem or collecting additional data that may allow correction during the estimation stage. As new inference methods are developed, it would be preferable if they were released as open source programmes in commonly used statistics packages (R, STATA, SAS etc) so they can be more easily evaluated and compared to existing methods. RDS has undoubtedly generated a wealth of new data on populations that have historically been difficult to access, and RDS is here to stay. The challenge now is to improve the methods (both sampling and inference) and ensure studies are reported well enough so that we can make the most of these data to improve public health.
  6 in total

1.  Commentary: Respondent-driven Sampling in the Real World.

Authors:  Matthew J Salganik
Journal:  Epidemiology       Date:  2012-01       Impact factor: 4.822

2.  Assessing respondent-driven sampling.

Authors:  Sharad Goel; Matthew J Salganik
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

Review 3.  Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review.

Authors:  Mohsen Malekinejad; Lisa Grazina Johnston; Carl Kendall; Ligia Regina Franco Sansigolo Kerr; Marina Raven Rifkin; George W Rutherford
Journal:  AIDS Behav       Date:  2008-06-17

4.  Subpopulations of illicit drug users reached by targeted street outreach and respondent-driven sampling strategies: implications for research and public health practice.

Authors:  Abby E Rudolph; Natalie D Crawford; Carl Latkin; Robert Heimer; Ebele O Benjamin; Kandice C Jones; Crystal M Fuller
Journal:  Ann Epidemiol       Date:  2011-04       Impact factor: 3.797

5.  Evaluation of respondent-driven sampling.

Authors:  Nicky McCreesh; Simon D W Frost; Janet Seeley; Joseph Katongole; Matilda N Tarsh; Richard Ndunguse; Fatima Jichi; Natasha L Lunel; Dermot Maher; Lisa G Johnston; Pam Sonnenberg; Andrew J Copas; Richard J Hayes; Richard G White
Journal:  Epidemiology       Date:  2012-01       Impact factor: 4.822

6.  AN EMPIRICAL TEST OF RESPONDENT-DRIVEN SAMPLING: POINT ESTIMATES, VARIANCE, DEGREE MEASURES, AND OUT-OF-EQUILIBRIUM DATA.

Authors:  Cyprian Wejnert
Journal:  Sociol Methodol       Date:  2009-08-01
  6 in total
  39 in total

1.  Nonparametric Identification for Respondent-Driven Sampling.

Authors:  Peter M Aronow; Forrest W Crawford
Journal:  Stat Probab Lett       Date:  2015-11-01       Impact factor: 0.870

2.  HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling.

Authors:  Alexander R Bazazi; Forrest Crawford; Alexei Zelenev; Robert Heimer; Adeeba Kamarulzaman; Frederick L Altice
Journal:  AIDS Behav       Date:  2015-12

3.  Getting to 90: linkage to HIV care among men who have sex with men and people who inject drugs in India.

Authors:  Allison M McFall; Shruti H Mehta; Aylur K Srikrishnan; Gregory M Lucas; Canjeevaram K Vasudevan; David D Celentano; Muniratnam S Kumar; Suniti Solomon; Sunil S Solomon
Journal:  AIDS Care       Date:  2016-04-07

4.  Time Since Migration and HIV Risk Behaviors Among Puerto Ricans Who Inject Drugs in New York City.

Authors:  Camila Gelpí-Acosta; Enrique R Pouget; Kathleen H Reilly; Holly Hagan; Alan Neaigus; Travis Wendel; David M Marshall
Journal:  Subst Use Misuse       Date:  2016-04-21       Impact factor: 2.164

5.  High HIV prevalence and incidence among MSM across 12 cities in India.

Authors:  Sunil S Solomon; Shruti H Mehta; Aylur K Srikrishnan; Canjeevaram K Vasudevan; Allison M Mcfall; Pachamuthu Balakrishnan; Santhanam Anand; Panneerselvam Nandagopal; Elizabeth L Ogburn; Oliver Laeyendecker; Gregory M Lucas; Suniti Solomon; David D Celentano
Journal:  AIDS       Date:  2015-03-27       Impact factor: 4.177

6.  Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.

Authors:  Allison M McFall; Sunil S Solomon; Greg M Lucas; David D Celentano; Aylur K Srikrishnan; Muniratnam S Kumar; Shruti H Mehta
Journal:  Addiction       Date:  2017-04-18       Impact factor: 6.526

7.  Prevalence of and Risk Factors for Anal Human Papillomavirus Infection in a Sample of Young, Predominantly Black Men Who Have Sex With Men, Houston, Texas.

Authors:  Alan G Nyitray; Kayo Fujimoto; Jing Zhao; Anna R Giuliano; John A Schneider; Lu-Yu Hwang
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

8.  Diverse Rates of Depression Among Men Who Have Sex with Men (MSM) Across India: Insights from a Multi-site Mixed Method Study.

Authors:  Cecilia Tomori; Allison M McFall; Aylur K Srikrishnan; Shruti H Mehta; Sunil S Solomon; Santhanam Anand; Canjeevaram K Vasudevan; Suniti Solomon; David D Celentano
Journal:  AIDS Behav       Date:  2016-02

9.  Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia.

Authors:  Anneli Uusküla; David M Barnes; Mait Raag; Ave Talu; Susan Tross; Don C Des Jarlais
Journal:  Drug Alcohol Depend       Date:  2018-05-08       Impact factor: 4.492

10.  The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.

Authors:  Suzan M Walters; Bethany Coston; Alan Neaigus; Alexis V Rivera; Lila Starbuck; Valentina Ramirez; Kathleen H Reilly; Sarah L Braunstein
Journal:  Int J Drug Policy       Date:  2020-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.